Infection and Chemotherapy
ISSN : 2093-2340 eISSN : 2092-6448
Abbreviation : Infect. Chemother.
Aims & Scope
Infection & Chemotherapy (Infect Chemother) is an international, peer-reviewed, and open-access journal in English, which publishes the current research on issues posed by infectious diseases worldwide.
This journal, which is published quarterly (on the last day of March, June, September, and December) in both print and online versions, is the only official publication of the Korean Society of Infectious Diseases , Korean Society for Antimicrobial Therapy (formerly Korean Society for Chemotherapy) , and the Korean Society for AIDS (http://www.kosaids.or.kr/).
It publishes review articles, original articles, brief communications, correspondences, case reports, editorials, and special articles covering an extensive range of clinical descriptions on infectious diseases, public health issues, microbiology including emerging resistance, parasitology and immunity to microbes, current and novel treatments, and the promotion of optimal practices or guidelines for diagnoses and treatments.
As the world continues to shrink as a result of globalization, it is necessary that appropriate communication is maintained among countries for timely sharing of information on infectious diseases.
This is an important topic because such diseases tend to have unique biologic features according to the regions in which they develop, and these diseases can easily become niduses that may spread globally at any time.
Based on these factors, the aim of this publication is to facilitate communication among societies and countries, enabling the worldwide sharing of information on infectious diseases.
The scope of this journal is to link basic and clinical research in the field of infectious diseases, in reference to relevant evidence.
The journal continuously attempts to publish current global and regional topics concerning infectious diseases and their diagnoses and managements to create awareness of related issues and link various developing and developed countries.
View Aims & ScopeMetrics & Ranking
Impact Factor
Year | Value |
---|---|
2025 | 2.9 |
2024 | 2.80 |
Journal Rank
Year | Value |
---|---|
2024 | 8317 |
Journal Citation Indicator
Year | Value |
---|---|
2024 | 550 |
SJR (SCImago Journal Rank)
Year | Value |
---|---|
2024 | 0.685 |
Quartile
Year | Value |
---|---|
2024 | Q2 |
h-index
Year | Value |
---|---|
2024 | 40 |
Impact Factor Trend
Abstracting & Indexing
Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.
Subjects & Keywords
Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.
Licensing & Copyright
This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.
Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.
Policy Links
This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.
- Aims scope
- Homepage
- Oa statement
- Author instructions
- License terms
- Review url
- Board url
- Copyright url
- Plagiarism url
- Preservation url
- Apc url
- License
Plagiarism Policy
This journal follows a plagiarism policy. All submitted manuscripts are screened using reliable plagiarism detection software to ensure originality and academic integrity. Authors are responsible for proper citation and acknowledgment of all sources, and any form of plagiarism, including self-plagiarism, will not be tolerated.
For more details, please refer to our official: Plagiarism Policy.
APC Details
The journal’s Article Processing Charge (APC) policies support open access publishing in Medicine, ensuring accessibility and quality in research dissemination.
This journal does not charge a mandatory Article Processing Charge (APC). However, optional open access publication may incur fees based on the publisher’s policies.
Explore journals without APCs for alternative publishing options.
Most Cited Articles
The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.
-
Age-Related Morbidity and Mortality among Patients with COVID-19
Citation: 401
Authors: Seung-Ji, Sook In
-
Cytomegalovirus Infections in Solid Organ Transplantation: A Review
Citation: 284
Authors: Poornima, Raymund R
-
Epidemiology and Characteristics of Metallo-β-Lactamase-Producing<i>Pseudomonas aeruginosa</i>
Citation: 219
Authors: Duck Jin, Il Kwon, In-Ho, Seok Hoon, Hyun-Kyung, Kyungwon
-
Praziquantel Treatment in Trematode and Cestode Infections: An Update
Citation: 197
Authors: Jong-Yil
-
Clinical Practice Guidelines for the Antibiotic Treatment of Community-Acquired Urinary Tract Infections
Citation: 157
Authors: Cheol-In, Jieun, Dae Won, Baek-Nam, U-Syn, Seung-Ju, Jeong Kyun, Seung Ki, Heeyoung, Seong-Heon
-
Genomic Basis for Methicillin Resistance in<i>Staphylococcus aureus</i>
Citation: 155
Authors: Keiichi, Teruyo, Sae, Takashi, Fumihiko, Yuh, Yuki, Miki, Kyoko, Tomomi, Tadashi
-
Treatment of Methicillin-Resistant <i>Staphylococcus aureus</i> Bacteremia
Citation: 133
Authors: Eun Ju, Henry F.
-
Omega 3 Fatty Acids and COVID-19: A Comprehensive Review
Citation: 114
Authors: Donald, Krunal, Madhusudan, Adrian, Bishnu Mohan, Aayushi, Zar Chi, Sarabjot, Muhammad Khawar, Rafael, Rockeven, Michael Maher Mourad, Susan, Ivan, Alina, Rafael
-
Antimicrobial Resistance in Asia: Current Epidemiology and Clinical Implications
Citation: 112
Authors: Cheol-In, Jae-Hoon